Events › Healthcare & MedTech
Healthcare & MedTech
45
Exhibitors
4,700
Attendees
An international medical and scientific conference focused on presenting breakthroughs in treatment, translational R&D, early diagnosis, drug development, and clinical trials for Alzheimer's, Parkinson's, and related neurological disorders.
Exhibitor mix: The exhibition floor is organized by sponsorship tier levels including Diamond, Platinum, Gold, Exhibitors, and a specialized Startup Hub.
International Conference on Alzheimer's and Parkinson's Diseases is held annually. This page tracks the next confirmed edition — International Conference on Alzheimer's and Parkinson's Diseases 2028 dates will be added here once announced.
Filter this event to your ICP.
45 exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
Venue
Centre de Convencions Internacional de BarcelonaMultipurpose · 100,000 m² · 1 halls · ~10,000 people
Managed by Fira de Barcelona, the CCIB is a premier, modern convention centre located on Barcelona's seafront in the Diagonal Mar area. It offers 100,000 sqm of total event space, including a 11,340 sqm main multipurpose hall and a separate 3,084-seat auditorium, hosting international congresses and exhibitions.
📍 Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain
Operated by Fira de Barcelona
Organizer
Kenes GroupPrivate · Geneva, Switzerland · Founded 1965
Professional congress organizer (PCO) and association management company specializing in medical and scientific events.
Why people attend
To evaluate new therapeutic solutions, source clinical trial technologies, discover novel biomarker assays, and network with leading central nervous system drug developers.
Who attends
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
86 speakers at International Conference on Alzheimer's and Parkinson's Diseases
"FROM ALZHEIMER’S TREATMENT AND BLOOD TESTS, TO PREVENTION, BRAIN AGING, AND AI-POWERED DISCOVERY"
"FLUID BIOMARKERS FOR TAU PATHOPHYSIOLOGY IN ALZHEIMER'S DISEASE—WHAT DO THEY REFLECT AND WHAT CAN THEY BE USED FOR?"
Also speaking at 12th Congress of the European Academy of Neurology
"MULTIMODAL BIOMARKER FOR PREVENTION TRIALS IN PD"
"ERIC N. BIRCH MEMORIAL LECTURE - MOLECULAR PATHOLOGY OF LEWY BODY DISEASES"
"CAN GENETICS CRACK NEURODEGENERATION? FROM DISCOVERY TO DISEASE MODIFICATION?"
"THE ROLE OF VASCULAR DYSFUNCTION IN NEURODEGENERATION"
"HOW DO BRAIN MACROPHAGES SHAPE COGNITIVE RESILIENCE AND VULNERABILITY IN AGING AND DISEASE?"
"RECENT DEVELOPMENTS IN DIAGNOSTICS AND THERAPEUTICS"
"GBA-1 FOCUSED TRIALS IN PARKINSON'S"
"IN VIVO MODULATION OF MICROGLIAL MITOCHONDRIA-ER CONTACTS ALLEVIATES BRAIN INFLAMMATION IN AD MICE."
"DIGITAL IS THE LIFEBLOOD OF AI SOLUTIONS FOR AD/PD"
Also speaking at GIANT Health Event
"THE PERIPHERY IN THE PATHOMECHANISM OF SYNUCLEINOPATHIES"
"A NOVEL GENE THERAPY APPROACH TO TARGET MICROGLIA IN VIVO"
"CLINICAL TRIAL DESIGN CONSIDERATIONS FOR DISEASE-MODIFYING TRIALS IN REM SLEEP BEHAVIOR DISORDER"
"APOE-DEPENDENT LIPID DYSREGULATION IN ALZHEIMER’S DISEASE"
+ 70 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions